Correlation Between Mersana Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mersana Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mersana Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mersana Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Mersana Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mersana Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mersana Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Mersana Therapeutics and Terns Pharmaceuticals
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mersana and Terns is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Mersana Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mersana Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Mersana Therapeutics i.e., Mersana Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mersana Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Mersana Therapeutics is expected to generate 1.41 times less return on investment than Terns Pharmaceuticals. In addition to that, Mersana Therapeutics is 1.36 times more volatile than Terns Pharmaceuticals. It trades about 0.01 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about 0.03 per unit of volatility. If you would invest 566.00 in Terns Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 13.00 from holding Terns Pharmaceuticals or generate 2.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mersana Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Mersana Therapeutics |
| Terns Pharmaceuticals |
Mersana Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mersana Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Mersana Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mersana Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |